Rajiv Patni

Rajiv Patni currently works at Judo Bio, Inc., as Chief Executive Officer & Director from 2024 and BioXcel Therapeutics, Inc., as Director from 2025.
Dr. Patni also formerly worked at Roche Pharmaceuticals, Inc., as Executive Director & Vice President, Quince Therapeutics, Inc., as Independent Director from 2024 to 2026, Novartis Pharmaceuticals Corp., as Senior Medical Director, Pfizer Pharmaceuticals, Inc., as Senior Medical Director, Reata Pharmaceuticals, Inc., as Executive VP, Chief Research & Development Officer in 2023, Adamas Pharmaceuticals LLC, as Chief Medical Officer from 2015 to 2020, OCERA Therapeutics LLC, as Chief Development Officer from 2014 to 2015, Actelion Pharmaceuticals US, Inc., as Chief Medical Officer from 2007 to 2014, Portola Pharmaceuticals LLC, as Chief Medical Officer & Executive Vice President in 2020, and Global Blood Therapeutics, Inc., as Chief Medical Officer from 2020 to 2023.
Dr. Patni received his doctorate degree from Icahn School of Medicine at Mount Sinai and undergraduate degree from The Sophie Davis School of Biomedical Education.